Emerging Issues and New Frontiers for FDA Regulation
October 20, 2014 8:00 AM – 5:00 PM
Alston & Bird, The Atlantic Building, 950 F Street, NW, Washington, DC 20004-1404
Registration is now open online. A limited number of free seats are available to Harvard affiliates. For more information or to request a seat, please email us at petrie-flom@law.harvard.edu by October 7th.
Please join the Food and Drug Law Institute and the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School for an academic symposium on cutting-edge legal and regulatory issues facing FDA. Leading academics will present papers on mobile health, stem cells, personalized medicine, and other novel medical product issues, as well as food regulation. Papers will be available to registered attendees in advance, and will be published in an upcoming issue of the Food and Drug Law Journal.
Registration Fees (Note: “Member” and “Non-Member” rates refer to membership in FDLI.)
$395 Member
$495 Non-Member
$295 Government/Non-Profit Member
$395 Government/Non-Profit Non-Member
$50 Student Member
$75 Student Non-Member
$75 Academic Member
$100 Academic Non-Member
Symposium co-sponsored by the Food and Drug Law Institute (FDLI) and the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School.
